Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A prescriber-level guide to identifying, grading, and managing adverse events associated with GH secretagogue therapy, including ipamorelin, sermorelin, CJC-1295, and MK-677. Covers mechanism-based toxicity, monitoring schedules, and dose-adjustment algorithms.
Read clinical reviewA prescriber-level guide to growth hormone secretagogue drug classes, coding strategy, prior-authorization tactics, and compounding compliance for ipamorelin, sermorelin, tesamorelin, and MK-677.
Read clinical reviewA prescriber-level monograph covering the pharmacology, clinical evidence, dosing, safety, and monitoring of the growth hormone secretagogue drug class, including ipamorelin, sermorelin, tesamorelin, and MK-677.
Read clinical reviewComplete drug-drug interaction (DDI) reference for growth hormone secretagogues including ipamorelin, CJC-1295, tesamorelin, sermorelin, and MK-677. Written for prescribers and pharmacists.
Read clinical reviewA physician-level guide to monitoring patients on GH secretagogues (ipamorelin, CJC-1295, MK-677, GHRP-2, GHRP-6). Covers baseline labs, on-therapy intervals, dose titration, safety signals, and discontinuation criteria with primary-source citations.
Read clinical reviewA clinical-level review of growth hormone secretagogue prescribing in special populations including older adults, women, athletes, and patients with metabolic disease. Covers ipamorelin, sermorelin, CJC-1295, MK-677, and GHRP-6 with dose guidance, contraindications, and monitoring.
Read clinical reviewA prescriber-level guide to titrating and tapering growth hormone secretagogues including ipamorelin, CJC-1295, sermorelin, and MK-677. Covers dose escalation schedules, monitoring parameters, and evidence-based tapering protocols.
Read clinical reviewA clinical guide for prescribers and pharmacists on selecting between ipamorelin, sermorelin, CJC-1295, MK-677, hexarelin, and GHRP-6 based on mechanism, evidence, and patient-specific goals.
Read clinical review